Issued Patents All Time
Showing 26–50 of 73 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 7132244 | Betaine/GABA transport protein biopolymer marker indicative of insulin resistance | John Marshall | 2006-11-07 |
| 7125678 | Protein biopolymer markers predictive of type II diabetes | John Marshall | 2006-10-24 |
| 7125726 | Method and kit for diagnosing myocardial infarction | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2006-10-24 |
| 7122327 | Biopolymer markers indicative of type II diabetes | John Marshall | 2006-10-17 |
| 7109023 | Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients | Jemo Kang, Kyung Ah Kim, Joo Young Choi | 2006-09-19 |
| 7101680 | Method for detecting the presence of monomeric brain associated human glutamine synthetase | Miyoko Takahashi | 2006-09-05 |
| 7097989 | Complement C3 precursor biopolymer markers predictive of type II diabetes | John Marshall | 2006-08-29 |
| 7094549 | Fibronectin biopolymer marker indicative of insulin resistance | John Marshall | 2006-08-22 |
| 7087435 | Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2006-08-08 |
| 7074576 | Protein biopolymer markers indicative of alzheimer's disease | John Marshall | 2006-07-11 |
| 7070945 | Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment | Miyoko Takahashi | 2006-07-04 |
| 7052849 | Protein biopolymer markers predictive of insulin resistance | John Marshall | 2006-05-30 |
| 7049397 | Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2006-05-23 |
| 7026129 | IG lambda biopolymer markers predictive of Alzheimers disease | John Marshall | 2006-04-11 |
| 7015004 | Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance | John Marshall | 2006-03-21 |
| 7014854 | Method for retarding or precluding Alzheimer's dementia | Shirley Furesz | 2006-03-21 |
| 7008800 | Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2006-03-07 |
| 6998243 | Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2006-02-14 |
| 6890722 | HP biopolymer markers predictive of insulin resistance | John Marshall | 2005-05-10 |
| 6890763 | Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2005-05-10 |
| 6780606 | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein | — | 2004-08-24 |
| 6756476 | Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2004-06-29 |
| 6703366 | Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2004-03-09 |
| 6696264 | Method and apparatus for detection of multiple biological materials with a heterogeneous antibody mixture | William T. Bodenhamer, Eric Davies, Mansel Griffiths | 2004-02-24 |
| 6693080 | Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons | Brad Thatcher, John Marshall, Jason Yantha, Tammy Vrees | 2004-02-17 |